Teligent Income After Taxes 2010-2021 | TLGT
Teligent income after taxes from 2010 to 2021. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Teligent Annual Income After Taxes (Millions of US $) |
2020 |
$-122 |
2019 |
$-25 |
2018 |
$-36 |
2017 |
$-15 |
2016 |
$-12 |
2015 |
$7 |
2014 |
$5 |
2013 |
$-0 |
2012 |
$-4 |
2011 |
$-3 |
2010 |
$-3 |
2009 |
$-5 |
Teligent Quarterly Income After Taxes (Millions of US $) |
2021-06-30 |
$-13 |
2021-03-31 |
$2 |
2020-12-31 |
$-80 |
2020-09-30 |
$-1 |
2020-06-30 |
$-14 |
2020-03-31 |
$-27 |
2019-12-31 |
$-5 |
2019-09-30 |
$-7 |
2019-06-30 |
$-4 |
2019-03-31 |
$-9 |
2018-12-31 |
$-14 |
2018-09-30 |
$-4 |
2018-06-30 |
$-13 |
2018-03-31 |
$-5 |
2017-12-31 |
$-6 |
2017-09-30 |
$-9 |
2017-06-30 |
$-1 |
2017-03-31 |
$1 |
2016-12-31 |
$-5 |
2016-09-30 |
$-3 |
2016-06-30 |
$-3 |
2016-03-31 |
$-1 |
2015-12-31 |
$-6 |
2015-09-30 |
$-3 |
2015-06-30 |
$9 |
2015-03-31 |
$7 |
2014-12-31 |
$6 |
2014-09-30 |
$-0 |
2014-06-30 |
$-0 |
2014-03-31 |
$0 |
2013-12-31 |
$1 |
2013-09-30 |
$-0 |
2013-06-30 |
$-0 |
2013-03-31 |
$-0 |
2012-12-31 |
$-1 |
2012-09-30 |
$-1 |
2012-06-30 |
$-1 |
2012-03-31 |
$-1 |
2011-12-31 |
$-1 |
2011-09-30 |
$-0 |
2011-06-30 |
$-1 |
2011-03-31 |
$-1 |
2010-12-31 |
$-1 |
2010-09-30 |
$-1 |
2010-06-30 |
$-1 |
2010-03-31 |
$-1 |
2009-12-31 |
$-1 |
2009-09-30 |
$-1 |
2009-06-30 |
$-2 |
2009-03-31 |
$-1 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|